Development of Protein Mimics for Intracellular Delivery
Overview
Authors
Affiliations
Designing delivery agents for therapeutics is an ongoing challenge. As treatments and desired cargoes become more complex, the need for improved delivery vehicles becomes critical. Excellent delivery vehicles must ensure the stability of the cargo, maintain the cargo's solubility, and promote efficient delivery and release. In order to address these issues, many research groups have looked to nature for design inspiration. Proteins, such as HIV-1 trans-activator of transcription (TAT) and Antennapedia homeodomain protein, are capable of crossing cellular membranes. However, due to the complexities of their structures, they are synthetically challenging to reproduce in the laboratory setting. Being able to incorporate the key features of these proteins that enable cell entry into simpler scaffolds opens up a wide range of opportunities for the development of new delivery reagents with improved performance. This review charts the development of protein mimics based on cell-penetrating peptides (CPPs) and how structure-activity relationships (SARs) with these molecules and their protein counterparts ultimately led to the use of polymeric scaffolds. These scaffolds deviate from the normal peptide backbone, allowing for simpler, synthetic procedures to make carriers and tune chemical compositions for application specific needs. Successful design of polymeric protein mimics would allow researchers to further understand the key features in proteins and peptides necessary for efficient delivery and to design the next generation of more efficient delivery reagents.
Sequence Design of Random Heteropolymers as Protein Mimics.
Jayapurna I, Ruan Z, Eres M, Jalagam P, Jenkins S, Xu T Biomacromolecules. 2023; 24(2):652-660.
PMID: 36638823 PMC: 9930114. DOI: 10.1021/acs.biomac.2c01036.
Callmann C, Thompson M, Gianneschi N Acc Chem Res. 2020; 53(2):400-413.
PMID: 31967781 PMC: 11042489. DOI: 10.1021/acs.accounts.9b00518.
Engineering toxin complex (PTC) into a recombinant injection nanomachine.
Ng Ang A P, Ebner J, Plessner M, Aktories K, Schmidt G Life Sci Alliance. 2019; 2(5).
PMID: 31540947 PMC: 6756610. DOI: 10.26508/lsa.201900485.
Hibbitts A, OConnor A, McCarthy J, Forde E, Hessman G, ODriscoll C ACS Omega. 2019; 4(6):10078-10088.
PMID: 31460100 PMC: 6647993. DOI: 10.1021/acsomega.9b00265.
Protein Transduction Domain Mimic (PTDM) Self-Assembly?.
Posey N, Tew G Polymers (Basel). 2019; 10(9).
PMID: 30960964 PMC: 6403535. DOI: 10.3390/polym10091039.